|
FRLN
|
Freeline Therapeutics Holdings plc
|
US
|
NASDAQ
|
|
FSI
|
Flexible Solutions International Inc.
|
US
|
AMEX
|
|
GBIO
|
Generation Bio Co.
|
US
|
NASDAQ
|
|
GENE
|
Genetic Technologies Ltd
|
US
|
NASDAQ
|
|
GERM
|
ETFMG Treatments Testing and Advancements ETF
|
US
|
AMEX
|
|
GERN
|
Geron Corporation
|
US
|
NASDAQ
|
|
GLTO
|
Galecto, Inc.
|
US
|
NASDAQ
|
|
GNPX
|
Genprex, Inc.
|
US
|
NASDAQ
|
|
GNTA
|
Genenta Science S.p.A.
|
US
|
NASDAQ
|
|
GRNA
|
GreenLight Biosciences Holdings, PBC
|
US
|
NASDAQ
|
|
GRPH
|
Graphite Bio, Inc.
|
US
|
NASDAQ
|
|
GTH
|
Genetron Holdings Limited
|
US
|
NASDAQ
|
|
HBIO
|
Harvard Bioscience, Inc.
|
US
|
NASDAQ
|
|
HELX
|
Franklin Genomic Advancements ETF
|
US
|
AMEX
|
|
HILS
|
Hillstream BioPharma, Inc.
|
US
|
NASDAQ
|
|
HTGM
|
HTG Molecular Diagnostics, Inc.
|
US
|
NASDAQ
|
|
HYPR
|
Hyperfine, Inc.
|
US
|
NASDAQ
|
|
ICLR
|
ICON plc
|
US
|
NASDAQ
|
|
IDRA
|
Idera Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
IDXG
|
Interpace Diagnostics Group, Inc.
|
US
|
NASDAQ
|